ProTransit Nanotherapy Company
ProTransit Nanotherapy technology allows for the delivery of large molecular weight cargo like proteins, enzymes, DNA and RNA inside of the targeted cells. The underlying technology is expected to be used in a variety of disciplines, including skincare, neurological illnesses, diabetes, and cancer. The delivery of antioxidant enzymes in sunscreens and cosmetics to deep layers of skin, where they can help prevent premature wrinkles, age spots, and even cancer, will be the first of multiple uses for this technology.
Industry:
PharmTech
Headquarters:
Omaha, Nebraska, United States
Zip:
1-10
Founded Date:
2011-01-01
Employees Number:
1-10
Total Funding:
Less than $1M
Estimated Revenue:
Less than $1M
Register and Claim Ownership